The arterial blood collection devices market is experiencing notable trends influenced by factors such as technological advancements, increasing prevalence of chronic diseases, and a growing focus on patient safety and comfort. One significant trend in this market is the development of innovative arterial blood collection devices that offer improved ease of use, accuracy, and patient comfort. Manufacturers are introducing new designs and materials for arterial blood collection needles, syringes, and catheters to minimize pain, trauma, and complications associated with arterial punctures. These advancements enhance the overall experience for both patients and healthcare providers, driving the adoption of arterial blood collection devices in clinical settings.
Moreover, there is a growing demand for arterial blood gas (ABG) testing and point-of-care (POC) diagnostic solutions, driving the expansion of the arterial blood collection devices market. ABG analysis plays a critical role in the assessment and management of patients with respiratory and metabolic disorders, sepsis, and critical illnesses. As healthcare providers strive to improve patient outcomes and optimize treatment decisions, there is increasing reliance on POC testing devices that enable rapid, accurate, and real-time measurement of arterial blood gases, electrolytes, and metabolic parameters. This trend is driving the development of arterial blood collection devices compatible with POC analyzers and automated systems, facilitating seamless integration into clinical workflows and enhancing efficiency in critical care settings.
Furthermore, the arterial blood collection devices market is witnessing increasing adoption in non-traditional healthcare settings such as ambulatory care centers, home healthcare, and emergency medical services. As healthcare delivery models evolve and decentralize, there is growing demand for portable, user-friendly arterial blood collection devices that can be used outside of traditional hospital settings. This includes handheld arterial blood gas analyzers, pre-packaged arterial blood collection kits, and disposable arterial catheters designed for ease of use and safety in non-clinical environments. These devices enable timely and accurate assessment of patients' respiratory and metabolic status, facilitating rapid decision-making and appropriate interventions in diverse healthcare settings.
Additionally, regulatory changes and quality standards are shaping the arterial blood collection devices market, particularly in terms of safety, sterility, and traceability requirements. Regulatory agencies such as the FDA and European Medicines Agency (EMA) are implementing stricter regulations and guidelines for the design, manufacturing, and labeling of arterial blood collection devices to ensure patient safety and product quality. This includes requirements for biocompatibility testing, sterilization validation, and risk management processes to mitigate potential hazards associated with arterial blood collection procedures. Furthermore, healthcare organizations are implementing quality management systems and accreditation standards such as ISO 15189 and Clinical Laboratory Improvement Amendments (CLIA) to ensure compliance with best practices and quality standards for arterial blood gas testing and diagnostic services.
Moreover, there is a growing emphasis on sustainability and environmental stewardship in the arterial blood collection devices market, driven by increasing awareness of healthcare-related waste and carbon footprint. Manufacturers are exploring eco-friendly materials, packaging solutions, and disposal methods to minimize the environmental impact of arterial blood collection devices throughout their lifecycle. This includes the use of recyclable materials, bio-based polymers, and reduced packaging waste in product design and manufacturing processes. Additionally, there is growing interest in reusable arterial blood collection devices and accessories that can be sterilized and reprocessed for multiple uses, reducing the volume of single-use medical waste generated in healthcare facilities.
The Arterial Blood Collection Devices Market Size was valued at USD 9,333.88 Billion in 2023. The Global Arterial Blood Collection Devices industry is projected to grow from USD 9,738.13 Billion in 2024 to USD 14,602.90 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.20% during the forecast period (2024 - 2032).
An arterial blood sample is collected from the artery with the help of arterial blood collection devices. Arterial blood collection should be performed only by healthcare professionals after acquiring proper knowledge and training. Devices for arterial blood collection are needed to be sterile to avoid infection to the healthcare professionals and patients during blood collection. Arterial blood collection devices are mostly used for arterial blood gas sampling. According to Medline, arterial blood samples should be performed under anaerobic conditions, and the sample should be placed on ice and held at 0° C until analysis.
The blood collection devices market is showing positive growth, which can be attributed to an increase in the demand for safe blood collection devices, aging population suffering from chronic disease, and demand of diagnosis of chronic diseases.
Market Dynamics
Availability of blood before any surgical procedure is of prime importance to the surgical team. In case of substantial blood loss, a blood transfusion may be required. Hence, the demand for safe and efficient blood collection devices is increasing with an increase in the number of surgical procedures as a pre-operative measure.
Furthermore, to avoid delay of scheduled cases, blood samples are collected three days before the date of surgery. Nowadays, providing blood components to the pre-operative patient has become a necessity. Therefore, collecting blood samples with the help of sterile blood collection devices is important, which contributes to the growth of arterial blood collection devices market.
Segmentation
There is a large number of blood collection devices for venous and arterial blood collection. In the case of arterial blood collection, the blood sample is collected from the artery to determine arterial blood gases. Based on type, the blood collection devices market is segmented into blood collection tubes, lancet, needles, vacuum blood collection system, microfluidic system, and other devices. Other devices include arterial cannula and blood bags.
Arterial blood collection devices have several applications in the diagnosis and treatment of disease. With the help of a blood test, the healthcare provider can diagnose the progress of disease and determine the line of treatment. Arterial blood collection devices are used for arterial blood gas sampling & intraoperative blood salvage. Based on application, the arterial blood collection market is divided into arterial blood gas sampling and intraoperative blood salvage. Arterial blood gas sampling is further sub-segmented into diagnosis of disease and acid-base status monitoring.
Based on end user, the blood collection devices market is segmented into hospitals & clinics, laboratories, blood banks, and others. Other end users include ambulatory surgery centers.
Key Players
The prominent players in the blood collection devices market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., NIPRO Medical Corporation, QIAGEN, F. Hoffmann-La Roche Ltd, Terumo Medical Corporation, and Thermo Fisher Scientific, Inc.
The players operating in the arterial blood collection market are focusing on product launches and expanding their global footprints by entering untapped markets.
Market Segmentation
Type Outlook
Application Outlook
End User Outlook
Region Outlook
Available Additional Customizations
Company Profiles of Key Regional Players
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)